{"disease":{"id":"acoustic-schwannoma","name":"acoustic schwannoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01125046","title":"Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT06844461","title":"Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT06322342","title":"Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Reveal Pharmaceuticals Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}